학술논문
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma
Document Type
Article
Author
Source
In: Oncologist . (Oncologist, February 2024, 29(2):142-150)
Subject
Language
English
ISSN
1549490X
10837159
10837159